| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.3 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.3 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |